Showing results (111-120 of 148) with videos related to
Sort By:
Pageof 15
In Vivo (Athens, Greece)|October 24, 2018
Soluble Thrombomodulin Attenuates Endothelial Cell Damage in Hepatic Sinusoidal Obstruction SyndromeSatoshi Takada, Tomoharu Miyashita, Yasuhiko Yamamoto, et al.International Journal of Oncology|December 18, 2015
Concentration-dependent radiosensitizing effect of docetaxel in esophageal squamous cell carcinoma cellsShohei Miyanaga, Itasu Ninomiya, Tomoya Tsukada, et al.Oncology Letters|September 12, 2012
Giant serous microcystic adenoma of the pancreas safely resected after preoperative arterial embolizationHidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.Pancreas|February 23, 2022
Verification of Resectability Status for Pancreatic Cancer: Radiological and Pathological Analysis of Patients Undergoing Pancreatoduodenectomy With Combined Resection of the Superior Mesenteric ArteryIsamu Makino, Hidehiro Tajima, Hirohisa Kitagawa, et al.Anticancer Research|October 2, 2019
Impact of Extravasated Platelet Activation and Podoplanin-positive Cancer-associated Fibroblasts in Pancreatic Cancer StromaTomoharu Miyashita, Hidehiro Tajima, Ryosuke Gabata, et al.Experimental and Therapeutic Medicine|March 18, 2015
Extravasated platelet aggregation in liver zone 3 may correlate with the progression of sinusoidal obstruction syndrome following living donor liver transplantation: A case reportShinichi Nakanuma, Tomoharu Miyashita, Hironori Hayashi, et al.Molecular and Clinical Oncology|January 8, 2021
A phase I study of preoperative (neoadjuvant) chemotherapy with gemcitabine plus nab-paclitaxel for resectable pancreatic cancerHidehiro Tajima, Isamu Makino, Ryosuke Gabata, et al.Oncology Reports|October 18, 2016
Expression status of CD44 and CD133 as a prognostic marker in esophageal squamous cell carcinoma treated with neoadjuvant chemotherapy followed by radical esophagectomyKoichi Okamoto, Itasu Ninomiya, Yoshinao Ohbatake, et al.Experimental and Therapeutic Medicine|September 21, 2012
Hepatic arterial infusion chemotherapy for post-operative liver metastases from pancreatic cancer in a patient with leukocytopenia: A case reportHidehiro Tajima, Tetsuo Ohta, Hirohisa Kitagawa, et al.Molecular and Clinical Oncology|March 21, 2018
Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancerHidehiro Tajima, Mitsuyoshi Okazaki, Takahisa Yamaguchi, et al.Pageof 15